12 West Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

12 West Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-735,000	Closed	-$95.5M	–	15
2020 Q4	$95.5M	Hold	735,000	–	–	4.1%	7
2020 Q3	$107M	Hold	735,000	–	–	5.21%	6
2020 Q2	$109M	Hold	735,000	–	–	5.63%	6
2020 Q1	$80M	Hold	735,000	–	–	4.77%	6
2019 Q4	$84.7M	Hold	735,000	–	–	5.34%	7
2019 Q3	$59.1M	Hold	735,000	–	–	3.81%	10
2019 Q2	$53.3M	Hold	735,000	–	–	4.01%	10
2019 Q1	$68.7M	Hold	735,000	–	–	5.6%	6
2018 Q4	$53.6M	Hold	735,000	–	–	5.52%	6
2018 Q3	$64.3M	Hold	735,000	–	–	4.72%	8
2018 Q2	$72.4M	Buy	735,000 +35,000	+5%	+$3.47M	5.97%	7
2018 Q1	$83.4M	Hold	700,000	–	–	9.17%	6
2017 Q4	$88.9M	Hold	700,000	–	–	10.75%	4
2017 Q3	$82.2M	Hold	700,000	–	–	11.5%	4
2017 Q2	$55.8M	Hold	700,000	–	–	9.45%	5
2017 Q1	$35.9M	Hold	700,000	–	–	7.13%	5
2016 Q4	$26.2M	Hold	700,000	–	–	4.66%	7
2016 Q3	$47.4M	Hold	700,000	–	–	6.8%	4
2016 Q2	$38.8M	Buy	700,000 +4,000	+0.6%	+$252K	6.26%	4
2016 Q1	$43.7M	Buy	696,000 +45,000	+7%	+$2.99M	6.07%	5
2015 Q4	$61.3M	Hold	651,000	–	–	8.75%	4
2015 Q3	$52.3M	Hold	651,000	–	–	7.63%	4
2015 Q2	$78M	Hold	651,000	–	–	8.91%	4
2015 Q1	$68M	Hold	651,000	–	–	7.56%	5
2014 Q4	$63.1M	Hold	651,000	–	–	7.83%	5
2014 Q3	$50.8M	Buy	+651,000	New	+$42M	5.93%	5

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

12 West Capital Management's ALNY Position: Q1 2021 in Review

12 West Capital Management sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2021, closing a stake of 735,000 shares — an estimated $95.5M sold.

12 West Capital Management first reported a position in ALNY in Q3 2014 and held it in 26 quarters. The position peaked at $109M in Q2 2020. 391 funds tracked by Wall St. Rank hold ALNY as of Q1 2021.

12 West Capital Management reported no remaining Alnylam Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
12 West Capital Management sold 735,000 Alnylam Pharmaceuticals shares in Q1 2021, an estimated $95.5M.
12 West Capital Management first reported a position in Alnylam Pharmaceuticals in Q3 2014 and held it in 26 quarters.
12 West Capital Management's Alnylam Pharmaceuticals position peaked at $109M in Q2 2020.
391 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2021.

Based on 12 West Capital Management's 13F filing for Q1 2021, filed 17 May 2021.